Intelligent Bio Solutions (INBS) EBIT Margin (2020 - 2024)
Historic EBIT Margin for Intelligent Bio Solutions (INBS) over the last 5 years, with Q1 2024 value amounting to 358.55%.
- Intelligent Bio Solutions' EBIT Margin rose 10730800.0% to 358.55% in Q1 2024 from the same period last year, while for Mar 2024 it was 359.87%, marking a year-over-year increase of 1541200.0%. This contributed to the annual value of 1002.11% for FY2023, which is 4691400.0% down from last year.
- According to the latest figures from Q1 2024, Intelligent Bio Solutions' EBIT Margin is 358.55%, which was up 10730800.0% from 260.63% recorded in Q4 2023.
- In the past 5 years, Intelligent Bio Solutions' EBIT Margin registered a high of 174.89% during Q2 2022, and its lowest value of 9158.69% during Q1 2021.
- For the 5-year period, Intelligent Bio Solutions' EBIT Margin averaged around 1364.04%, with its median value being 597.45% (2022).
- As far as peak fluctuations go, Intelligent Bio Solutions' EBIT Margin skyrocketed by 84611200bps in 2022, and later plummeted by -7340600bps in 2023.
- Over the past 5 years, Intelligent Bio Solutions' EBIT Margin (Quarter) stood at 1196.16% in 2020, then surged by 83bps to 201.67% in 2021, then tumbled by -196bps to 597.45% in 2022, then soared by 56bps to 260.63% in 2023, then plummeted by -38bps to 358.55% in 2024.
- Its last three reported values are 358.55% in Q1 2024, 260.63% for Q4 2023, and 317.35% during Q3 2023.